CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | DeYoung Casi Chief Business Officer | Shares withheld for taxes | −2,008 | $9.99 | $20K | 89,489 |
| 2024-01-12 | Schreiber Taylor Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +330,100 | 330,100 | ||
| 2024-01-10 | Shukla Abhinav A. Chief Technical Officer | Grant or award | +33,425 | 81,717 | ||
| 2024-01-10 | Shukla Abhinav A. Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +66,850 | 66,850 | ||
| 2024-01-10 | Stout Stephen See Remarks | Grant or award | +49,050 | 79,925 | ||
| 2024-01-10 | Stout Stephen See Remarks | Grant or award · Stock Option (Right to Buy) | +98,100 | 98,100 | ||
| 2024-01-10 | DeYoung Casi Chief Business Officer | Grant or award | +46,200 | 93,080 | ||
| 2024-01-10 | DeYoung Casi Chief Business Officer | Shares withheld for taxes | −1,583 | $10.09 | $16K | 91,497 |
| 2024-01-10 | DeYoung Casi Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +92,400 | 92,400 | ||
| 2024-01-10 | Neill Andrew R Chief Financial Officer | Grant or award 10b5-1 | +56,500 | 200,916 | ||
| 2024-01-10 | Neill Andrew R Chief Financial Officer | Shares withheld for taxes 10b5-1 | −2,470 | $10.09 | $25K | 198,446 |
| 2024-01-10 | Neill Andrew R Chief Financial Officer | Sale 10b5-1 | −25,000 | $10.00 | $250K | 173,446 |
| 2024-01-10 | Neill Andrew R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +113,000 | 113,000 | ||
| 2024-01-10 | Pandite Arundathy N. Chief Medical Officer | Grant or award | +46,475 | 222,267 | ||
| 2024-01-10 | Pandite Arundathy N. Chief Medical Officer | Shares withheld for taxes | −2,987 | $10.09 | $30K | 219,280 |
| 2024-01-10 | Pandite Arundathy N. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +92,950 | 92,950 | ||
| 2023-12-21 | Redmile Group, LLC Director | Grant or award · Pre-Funded Warrant to Purchase Common Stock | +3,100,823 | 3,100,823 | ||
| 2023-05-26 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-26 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-26 | Boudreau Helen M Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 |
Page 8 of 9 · 170 trades